ARMP · Armata Pharmaceuticals, Inc. · Fails to Deliver
$3.52
+0.21 (+6.34%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Our existing cash and cash equivalents of $24.0 million as of June 30, 2026 will not be sufficient to enable us to complete all necessary development of any potential product candidates and fund our operations for the next 12 months from the date the condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q are issued. These circumstances raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 12, 2026
Market Cap
$133.67M
Shares
37.18M
Volume · Oct 2
124.48K
Avg daily vol (3M)
213.34K
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-09-14 | 418 | $5.38 | $2,249 |
| 2026-09-11 | 900 | $5.23 | $4,707 |
| 2026-09-10 | 981 | $5.41 | $5,307 |
| 2026-09-04 | 2,116 | $5.52 | $11,680 |
| 2026-08-28 | 9 | $5.43 | $49 |
| 2026-08-27 | 1,426 | $5.45 | $7,772 |
| 2026-08-24 | 2,394 | $5.10 | $12,209 |
| 2026-08-20 | 4,159 | $5.07 | $21,086 |
| 2026-08-04 | 899 | $5.05 | $4,540 |
| 2026-07-28 | 671 | $5.15 | $3,456 |
| 2026-07-24 | 3 | $5.22 | $16 |
| 2026-07-23 | 1,772 | $5.24 | $9,285 |
| 2026-07-22 | 483 | $5.16 | $2,492 |
| 2026-07-20 | 92 | $4.51 | $415 |
| 2026-07-17 | 2,294 | $3.76 | $8,625 |
Showing 1–15 of 15 settlements